VIAVI CellAdvisor Base Station Analyzer Now Supports 28 GHz Frequency Band

VIAVI Solutions has announced that the CellAdvisor JD700B Series of Base Station Analyzers have been augmented to analyze spectrum and interference of 5G signals in the 28 GHz frequency band. CellAdvisor has been adopted by several Tier-1 mobile service providers as a standard test platform and is familiar to their cell site technicians, riggers and contractors. VIAVI has worked with their customer base to ensure that they can continue to use a single field test solution for existing and next-generation networks.

To accommodate the higher speeds envisioned in 5G, the industry is expanding to higher frequency bands than those used in preceding generations. Several network equipment manufacturers and service providers - including Ericsson, Huawei, Samsung, AT&T, Softbank, U.S. Cellular and Verizon - are conducting trials of 5G radios in the 28 GHz band.

To support customer demand for testing in 28 GHz, VIAVI has introduced a frequency downconverter for the CellAdvisor JD700B Series, enabling spectrum and interference analysis for the additional band using a familiar and proven platform. VIAVI collaborated with ThinkRF, a pioneer in software-defined spectrum analysis solutions that monitor, detect and analyze complex waveforms in today's rapidly evolving wireless landscape.

CellAdvisor Base Station Analyzers are trusted by mobile service providers, cell site technicians, riggers and contractors for their RFoCPRI and NB-IoT testing needs. The platform offers dual-port capability, cable and antenna analysis, spectrum analysis, interference analysis, signal analysis, demodulation and RF, optical power meters and optional fiber inspection in a rugged, portable, cloud-enabled instrument. Applications include: demodulation of all wireless technologies up to LTE; fiber inspection; interference analysis and PIM detection over CPRI; fronthaul and remote radio head verification over CPRI; and 5G spectrum and interference analysis. Click here to learn more.